LD-2 disclosure · 4th Quarter - Report
EMERGENT BIOSOLUTIONS
Income$50Kfee reported
Client
- Description
- Bio pharmaceutical company.
- Location
- District of Columbia · United States of America
Registrant
- Description
- Government affairs.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Providing guidance on development, acquisition and stockpiling of medical countermeasures for the US government. Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA). Funding for medical countermeasure enterprise including, SNS, BARDA and Project BioShield; State Opioid Response (SOR) Grant Funding; Substance Abuse and Mental Health Block Grant (SABG) funding. Naloxone access and awareness and opioid prescribing.
LobbyistsJEFFREY CARROLL
TargetedSENATE · HOUSE OF REPRESENTATIVES